Skip to main content
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1968 Jun;33(2):266–276. doi: 10.1111/j.1476-5381.1968.tb00988.x

Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone).

H W Osterlitz, A J Watt
PMCID: PMC1570231  PMID: 5664147

Full text

PDF
266

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blane G. F. Blockade of bradykinin-induced nociception in the rat as a test for analgesic drugs with particular reference to morphine antagonists. J Pharm Pharmacol. 1967 Jun;19(6):367–373. doi: 10.1111/j.2042-7158.1967.tb09562.x. [DOI] [PubMed] [Google Scholar]
  2. Blumberg H., Dayton H. B., Wolf P. S. Counteraction of narcotic antagonist analgesics by the narcotic antagonist Naloxone. Proc Soc Exp Biol Med. 1966 Dec;123(3):755–758. doi: 10.3181/00379727-123-31595. [DOI] [PubMed] [Google Scholar]
  3. EDDY N. B., HALBACH H., BRAENDEN O. J. Synthetic substances with morphine-like effect: clinical experience; potency, side-effects, addiction liability. Bull World Health Organ. 1957;17(4-5):569–863. [PMC free article] [PubMed] [Google Scholar]
  4. EDDY N. B., HALBACH H., BRAENDEN O. J. Synthetic substances with morphine-like effect; relationship between analgesic action and addiction liability, with a discussion of the chemical structure of addiction-producing substances. Bull World Health Organ. 1956;14(3):353–402. [PMC free article] [PubMed] [Google Scholar]
  5. FOLDES F. F., LUNN J. N., MOORE J., BROWN I. M. N-Allylnoroxy-morphone: a new potent narcotic antagonist. Am J Med Sci. 1963 Jan;245:23–30. [PubMed] [Google Scholar]
  6. FRASER H. F., ROSENBERG D. E. STUDIES ON THE HUMAN ADDICTION LIABILITY OF 2'-HYDROXY-5-9-DIMETHYL-2-(3,3-DIMETHYLALLYL)-6,7-BENZOMORPHAN (WIN 20,228): A WEAK NARCOTIC ANTAGONIST. J Pharmacol Exp Ther. 1964 Feb;143:149–156. [PubMed] [Google Scholar]
  7. Gyand E. A., Kosterlitz H. W. Agonist and antagonist actions of morphine-like drugs on the guinea-pig isolated ileum. Br J Pharmacol Chemother. 1966 Sep;27(3):514–527. doi: 10.1111/j.1476-5381.1966.tb01864.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jasinski D. R., Martin W. R., Haertzen C. A. The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone). J Pharmacol Exp Ther. 1967 Aug;157(2):420–426. [PubMed] [Google Scholar]
  9. Lasagna L. Drug interaction in the field of analgesic drugs. Proc R Soc Med. 1965 Nov;58(11 Pt 2):978–983. [PMC free article] [PubMed] [Google Scholar]
  10. Martin W. R., Fraser H. F., Gorodetzky C. W., Rosenberg D. E. Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2'-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, WIN-20,740, ARC II-c-3). J Pharmacol Exp Ther. 1965 Dec;150(3):426–436. [PubMed] [Google Scholar]
  11. Martin W. R., Gorodetzky C. W. Demonstration of tolerance to and physical dependence of N-allylnormorphine (nalorphine). J Pharmacol Exp Ther. 1965 Dec;150(3):437–442. [PubMed] [Google Scholar]
  12. McClane T. K., Martin W. R. Effects of morphine, nalorphine, cyclazocine, and naloxone on the flexor reflex. Int J Neuropharmacol. 1967 Mar;6(2):89–98. doi: 10.1016/0028-3908(67)90057-3. [DOI] [PubMed] [Google Scholar]
  13. SCHAUMANN W. Zusammenhänge zwischen der Wirkung der Analgetica und Sympathicomimetica auf den Meerschweinchen-Dunndarm. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1958;233(1):112–124. [PubMed] [Google Scholar]
  14. STEPHENSON R. P. A modification of receptor theory. Br J Pharmacol Chemother. 1956 Dec;11(4):379–393. doi: 10.1111/j.1476-5381.1956.tb00006.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. TELFORD J., PAPADOPOULOS C. N., KEATS A. S. Studies of analgesic drugs. VII. Morphine antagonists as analgesics. J Pharmacol Exp Ther. 1961 Jul;133:106–116. [PubMed] [Google Scholar]
  16. Winder C. V., Welford M., Wax J., Kaump D. H. Pharmacologic and toxicologic studies of m-(1-methyl-3-propyl-3-pyrrolidinyl)phenol (CI-572), an analgetic and antitussive agent. J Pharmacol Exp Ther. 1966 Oct;154(1):161–175. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES